KLU156

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KLU156, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria [Phase 3]

See pricing